Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

Wits RHI-Wits RHI Ward 21 Clinical Research site ( Site 0027), Johannesburg

Helen Joseph Hospital ( Site 0024), Johannesburg

Qhakaza Mbokodo Research Clinic ( Site 0026), Ladysmith

Desmond Tutu Health Foundation ( Site 0021), Cape Town

Josha Research ( Site 0023), Bloemfontein

University of Pittsburgh Medical Center-Division of Infectious Diseases ( Site 0041), Pittsburgh

Velocity Clinical Research Rockville ( Site 0048), Rockville

Velocity Clinical Research, Hallandale Beach ( Site 0052), Hallandale

Community Medical Care Center ( Site 0056), Immokalee

Prism Health North Texas, Oak Cliff Health Center ( Site 0045), Dallas

Albuquerque Clinical Trials, Inc. ( Site 0044), Albuquerque

Velocity Clinical Research, North Hollywood ( Site 0054), North Hollywood

Bridge HIV- San Francisco Department of Public Health ( Site 0042), San Francisco

Fred Hutchinson Cancer Center - The Seattle HIV Vaccine Trials Unit ( Site 0057), Seattle

Rambam Health Care Campus ( Site 0003), Haifa

Sheba Medical Center ( Site 0001), Ramat Gan

Hadassah Medical Center ( Site 0002), Jerusalem

Fenway Health ( Site 0043), Boston